1. OAR@UM
  2. Faculty of Medicine and Surgery
  3. Department of Pharmacy
  4. Scholarly Works - FacM&SPha
Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/50027
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2020-01-07T09:08:23Z-
dc.date.available2020-01-07T09:08:23Z-
dc.date.issued2017-09-
dc.identifier.citationCardona, M., Wirth, F., Serracino-Inglott, A., & Azzopardi, L. M. (2017, September). Drug interactions and bleeding complications with rivaroxaban compared to warfarin. Poster session presented at the FIP Annual Conference, Seoul, Republic of Korea.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/50027-
dc.description.abstractA poster presentation regarding drug interactions and bleeding complications with rivaroxaban compared to warfarin. Introduction: Compared to warfarin, the novel oral anticoagulant (NOAC) rivaroxaban has the advantages of a fixed dosing regimen with no need for INR monitoring and fewer potential drug-drug interactions (DDIs). However, there is conflicting evidence regarding bleeding complications. Aims: • To determine INR control for patients on warfarin; • To compare warfarin to rivaroxaban with respect to potential DDIs and incidence and severity of bleeding.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Department of Pharmacyen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectRivaroxabanen_GB
dc.subjectAnticoagulants (Medicine) -- Complications -- Case studiesen_GB
dc.subjectAnticoagulants (Medicine) -- Malta -- Case studiesen_GB
dc.subjectDrug interactionsen_GB
dc.subjectWarfarinen_GB
dc.subjectCardiovascular Disease -- Chemotherapyen_GB
dc.titleDrug interactions and bleeding complications with rivaroxaban compared to warfarinen_GB
dc.typepresentationen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorCardona, Mark-
dc.contributor.creatorWirth, Francesca-
dc.contributor.creatorSerracino-Inglott, Anthony-
dc.contributor.creatorAzzopardi, Lilian M.-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Drug_interactions_and_bleeding_complications_with_rivaroxaban_compared_to_warfarin_2017.pdf489.09 kBAdobe PDFView/Open
Show simple item record Statistics


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.